Latest News

2024 federal healthcare policy priorities: 340B reform, PBM oversight, and telehealth.

PDABs and upper-payment limits risk restricting medication access despite affordability intentions.

Payers face regulatory scrutiny for systematic coverage denials and prior authorization abuse.

340B reform must prioritize patients: charity care obligations and medical debt reduction.

Payers use prior authorization and step therapy to deny care, driving health disparities.

Innovative HIV medications available but inaccessible: payer barriers block Cabenuva and Apretude access.

85,000+ fake HIV medication bottles distributed through counterfeiting rings endanger patient safety.

AMA survey: 93% of providers say prior authorizations delay care with 91% reporting negative clinical impact.

Copay accumulator programs block patient assistance from counting toward deductibles; HELP Copays Act needed.

Payers restrict HCV treatment through utilization management; patient assistance programs fill the critical gap.

Analyzes CMS marketplace rule changes and Medicaid expansion risks as pandemic emergency declarations end.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.

Calls for restoring Obama-era guidance defining 340B patient protections and enforcement mechanisms.

Examines CMS's rebate rule on copay accumulator programs that block patient assistance from counting toward deductibles.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.